BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28658141)

  • 1. Pharmacogenetic and case-control study on potassium channel related gene variants and genetic generalized epilepsy.
    Qu J; Lu SH; Lu ZL; Xu P; Xiang DX; Qu Q
    Medicine (Baltimore); 2017 Jun; 96(26):e7321. PubMed ID: 28658141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies.
    Wu SZ; Ye H; Yang XG; Lu ZL; Qu Q; Qu J
    Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):226-233. PubMed ID: 29047147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-wide tagging study of the association between KCNT1 polymorphisms and the susceptibility and efficacy of genetic generalized epilepsy in Chinese population.
    Qu J; Zhang Y; Yang ZQ; Mao XY; Zhou BT; Yin JY; He H; Li XP; Long HY; Lv N; Xu XJ; Xiao B; Zhang Y; Tang Q; Hu DL; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2014 Feb; 20(2):140-6. PubMed ID: 24279416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.
    Rogers A; Golumbek P; Cellini E; Doccini V; Guerrini R; Wallgren-Pettersson C; Thuresson AC; Gurnett CA
    Am J Med Genet A; 2018 Aug; 176(8):1748-1752. PubMed ID: 30055040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Potassium Channel Gene Polymorphisms on Antiepileptic Drug Responsiveness in Arab Patients with Epilepsy.
    Al-Eitan LN; Al-Dalalah IM; Elshammari AK; Khreisat WH; Almasri AY
    J Pers Med; 2018 Nov; 8(4):. PubMed ID: 30441785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variants of KCNJ10 are associated with susceptibility and anti-epileptic drug resistance in Chinese genetic generalized epilepsies.
    Guo Y; Yan KP; Qu Q; Qu J; Chen ZG; Song T; Luo XY; Sun ZY; Bi CL; Liu JF
    PLoS One; 2015; 10(4):e0124896. PubMed ID: 25874548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sound Localization in Preweanling Mice Was More Severely Affected by Deleting the Kcna1 Gene Compared to Deleting Kcna2, and a Curious Inverted-U Course of Development That Appeared to Exceed Adult Performance Was Observed in All Groups.
    Ison JR; Allen PD; Tempel BL; Brew HM
    J Assoc Res Otolaryngol; 2019 Dec; 20(6):565-577. PubMed ID: 31410614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy.
    Vanhoof-Villalba SL; Gautier NM; Mishra V; Glasscock E
    Epilepsia; 2018 Feb; 59(2):358-368. PubMed ID: 29265344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility.
    Jorge BS; Campbell CM; Miller AR; Rutter ED; Gurnett CA; Vanoye CG; George AL; Kearney JA
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5443-8. PubMed ID: 21402906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kv1.1 and Kv1.2: similar channels, different seizure models.
    Robbins CA; Tempel BL
    Epilepsia; 2012 Jun; 53 Suppl 1():134-41. PubMed ID: 22612818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic variant "C588T" of GABARG2 is linked to childhood idiopathic generalized epilepsy and resistance to antiepileptic drugs.
    Abou El Ella SS; Tawfik MA; Abo El Fotoh WMM; Soliman OAM
    Seizure; 2018 Aug; 60():39-43. PubMed ID: 29894917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
    Manville RW; Abbott GW
    J Pharmacol Exp Ther; 2020 Jun; 373(3):391-401. PubMed ID: 32217768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental validation of in silico predicted KCNA1, KCNA2, KCNA6 and KCNQ2 genes for association studies of peripheral nerve hyperexcitability syndrome in Jack Russell Terriers.
    Van Poucke M; Vanhaesebrouck AE; Peelman LJ; Van Ham L
    Neuromuscul Disord; 2012 Jun; 22(6):558-65. PubMed ID: 22342001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
    Corbett MA; Bellows ST; Li M; Carroll R; Micallef S; Carvill GL; Myers CT; Howell KB; Maljevic S; Lerche H; Gazina EV; Mefford HC; Bahlo M; Berkovic SF; Petrou S; Scheffer IE; Gecz J
    Neurology; 2016 Nov; 87(19):1975-1984. PubMed ID: 27733563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epilepsy-associated K
    Nilsson M; Lindström SH; Kaneko M; Wang K; Minguez-Viñas T; Angelini M; Steccanella F; Holder D; Ottolia M; Olcese R; Pantazis A
    Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2113675119. PubMed ID: 35439054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variants of ATP1A3 but not ATP1A2 are associated with Chinese genetic generalized epilepsies.
    Qu J; Yang ZQ; Zhang Y; Mao CX; Wang ZB; Mao XY; Zhou BT; Yin JY; He H; Long HY; Gong JE; Xiao B; Zhou HH; Liu ZQ
    J Neurol Sci; 2015 Jul; 354(1-2):56-62. PubMed ID: 26003227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
    Imbrici P; D'Adamo MC; Kullmann DM; Pessia M
    Eur J Neurosci; 2006 Dec; 24(11):3073-83. PubMed ID: 17156368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic ablation or pharmacological inhibition of Kv1.1 potassium channel subunits impairs atrial repolarization in mice.
    Si M; Trosclair K; Hamilton KA; Glasscock E
    Am J Physiol Cell Physiol; 2019 Feb; 316(2):C154-C161. PubMed ID: 30427720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Spectrum of
    Paulhus K; Ammerman L; Glasscock E
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoresponsiveness of spontaneous recurrent seizures and the comorbid sleep disorder of epileptic Kcna1-null mice.
    Deodhar M; Matthews SA; Thomas B; Adamian L; Mattes S; Wells T; Zieba B; Simeone KA; Simeone TA
    Eur J Pharmacol; 2021 Dec; 913():174656. PubMed ID: 34838797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.